Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.

Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.

Item
http://www.wikidata.org/entity/Q34303495
Equol, a Dietary Daidzein Gut Metabolite Attenuates Microglial Activation and Potentiates Neuroprotection In VitroBeyond the Cholesterol-Lowering Effect of Soy Protein: A Review of the Effects of Dietary Soy and Its Constituents on Risk Factors for Cardiovascular DiseaseA holobiont birth narrative: the epigenetic transmission of the human microbiomeMicrobial ecology in Hydra: why viruses matter.Urolithins, the rescue of "old" metabolites to understand a "new" concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status.Cardiometabolic risk and gut microbial phytoestrogen metabolite phenotypes.The Gut-Brain Axis, BDNF, NMDA and CNS Disorders.Linking dietary patterns with gut microbial composition and function.Urinary enterolactone is associated with obesity and metabolic alteration in men in the US National Health and Nutrition Examination Survey 2001-10.Influence of Oral and Gut Microbiota in the Health of Menopausal Women.Metabolomics reveals differences between three daidzein metabolizing phenotypes in adults with cardiometabolic risk factors.Systematic review of the effects of the intestinal microbiota on selected nutrients and non-nutrients.Tart Cherries and health: Current knowledge and need for a better understanding of the fate of phytochemicals in the human gastrointestinal tract.Anti-obesity molecular mechanism of soy isoflavones: weaving the way to new therapeutic routes.The Nile Rat (Arvicanthis niloticus) as a Superior Carbohydrate-Sensitive Model for Type 2 Diabetes Mellitus (T2DM).Meta-Analysis of the Effects of Foods and Derived Products Containing Ellagitannins and Anthocyanins on Cardiometabolic Biomarkers: Analysis of Factors Influencing Variability of the Individual Responses.Gut microbiota derived metabolites in cardiovascular health and disease.
P2860

Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.

Item
http://www.wikidata.org/entity/Q34303495
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Obesity prevalence in relation ...... from the isoflavone daidzein.
@ast
Obesity prevalence in relation ...... from the isoflavone daidzein.
@en
Obesity prevalence in relation ...... from the isoflavone daidzein.
@nl
type
label
Obesity prevalence in relation ...... from the isoflavone daidzein.
@ast
Obesity prevalence in relation ...... from the isoflavone daidzein.
@en
Obesity prevalence in relation ...... from the isoflavone daidzein.
@nl
prefLabel
Obesity prevalence in relation ...... from the isoflavone daidzein.
@ast
Obesity prevalence in relation ...... from the isoflavone daidzein.
@en
Obesity prevalence in relation ...... from the isoflavone daidzein.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921
P932
P356
P1433
P1476
Obesity prevalence in relation ...... n from the isoflavone daidzein
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921
P932